Johnson & Johnson

3 trends tracked about this subject — the full history, oldest to newest below.

▲ Peaking Business

A $5.5 billion offer could finally end the decade‑long talc cancer lawsuits that have haunted Johnson & Johnson.

5 sources 5 articles v 14 4h ago

◼ Archived Business 🔮 fades ✗

Johnson & Johnson has exceeded quarterly earnings estimates and raised its financial guidance, driven by a strong performance in its medicines unit.

11 sources 12 articles v 10 12d ago

◼ Archived Business 🔮 fades ✓

Lilly, Johnson & Johnson and AbbVie stocks reach unprecedented levels as investors shift from tech to healthcare.

6 sources 6 articles v 4 31d ago